Trastuzumab pamirtecan, a HER2-targeted antibody-drug conjugate, achieved ‘exceptional’ antitumor responses in patients with recurrent endometrial cancer, especially those with HER2 IHC 3+ tumors.
Editor’s note: This is an automatically generated transcript. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription. Managing recurrent or hard-to-treat breast ...
Improvements seen in PFS, OS with Dato-DXd for previously untreated, locally recurrent inoperable or metastatic TNBC.
A recent study examines the association between COVID-19 infection and an increased risk of recurrence in breast cancer ...
Recurrent IRTC invading the upper aerodigestive tract remains a formidable clinical challenge. Management typically involves tracheal resection or laryngectomy, often with sacrifice of the recurrent ...
The PROSTATE-IQ trial uses the ArteraAI Prostate Test to personalize treatment for prostate cancer recurrence post-prostatectomy, potentially reducing hormone therapy use. The trial stratifies ...
When the kidney cancer known as renal cell carcinoma spreads to other places (metastatic) or comes back after remission (recurrent), you may need different types of treatment. Surgery can remove renal ...
Hosted on MSN
What You Need to Know About Lung Cancer Recurrence
Lung cancer recurrence is when cancer comes back after at least a year of being undetectable. Lung cancer often recurs within five years and is usually metastatic, meaning it has spread. Treatments ...
About one third of adult survivors of childhood cancer experience a clinically significant or high fear that their primary cancer may recur or that they will develop a subsequent malignancy, according ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results